EUVIMEDEUVIMED entdecken
Open Access

Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy

Thomas Boerner, Rebecca A Carr, Meier Hsu, Alexa Michel, Kay See Tan, Elvira Vos, Smita Sihag, Manjit S Bains, Geoffrey Y Ku, Abraham J Wu, David R Jones, Daniela Molena iD

International Journal of Cancer · 15.05.2023 · 152 (10) · 2109-2122

DOI: 10.1002/ijc.34417 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 05.01.2023. Verfasst von Thomas Boerner und 11 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Up to 50% of patients treated with curative esophagectomy for esophageal cancer will develop recurrence, contributing to the dismal survival associated with this disease. Regional recurrence may represent disease that is not yet widely metastatic and may therefore be amenable to more‐aggressive treatment. We sought to assess all patients treated with curative esophagectomy for esophageal cancer who developed regional recurrence. We retrospectively identified all patients who underwent esophagectomy for esophageal adenocarcinoma and esophageal squamous cell carcinoma at a single institution from January 2000 to August 2019. In total, 1626 patients were included in the study cohort. As of June 2022, 595 patients had disease recurrence, which was distant or systemic in 435 patients (27%), regional in 125 (7.7%) and local in 35 (2.2%). On multivariable analysis, neoadjuvant chemoradiation with a total radiation dose

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaCarcinoma, Squamous CellHumansEsophagectomyRetrospective StudiesIncidenceLymph NodesLymph Node ExcisionNeoplasm Recurrence, LocalSurvival Rate

Stichwörter der Autor:innen

curative esophagectomyesophageal cancerrecurrence

Autor:innen und Institutionen

  • Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

ORCID-Profile: Daniela Molena

Förderung

  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Boerner, T., Carr, R. A., Hsu, M., Michel, A., Tan, K. S., Vos, E., Sihag, S., Bains, M. S., Ku, G. Y., Wu, A. J., Jones, D. R., & Molena, D. (2023). Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy. International Journal of Cancer, 152(10), 2109-2122. https://doi.org/10.1002/ijc.34417

Vancouver

Boerner T, Carr RA, Hsu M, Michel A, Tan KS, Vos E, et al. Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy. International Journal of Cancer. 2023;152(10):2109-2122. doi:10.1002/ijc.34417

BibTeX
@article{Boerner2023,
  author = {Boerner, Thomas and Carr, Rebecca A and Hsu, Meier and Michel, Alexa and Tan, Kay See and Vos, Elvira and Sihag, Smita and Bains, Manjit S and Ku, Geoffrey Y and Wu, Abraham J and Jones, David R and Molena, Daniela},
  title = {Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy},
  journal = {International Journal of Cancer},
  year = {2023},
  volume = {152},
  number = {10},
  pages = {2109--2122},
  doi = {10.1002/ijc.34417}
}
Kostenlos starten →